MedTrace Logo

Risk of Cancer Among Pantoprazole Users

NCT01322633 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 61864

Last updated 2014-02-20

Study results available
· View outcomes & findings →

Summary

The primary objective is to assess whether the risk of gastric cancer is increased in pantoprazole users compared to users of other proton pump inhibitors.

Conditions

  • Esophagitis

Interventions

OTHER

Does not apply

This is a non-interventional study, therefore the intervention type / name do not apply.

OTHER

Does not apply

This is a non-interventional study, therefore the intervention type / name do not apply.

Sponsors & Collaborators

Principal Investigators

  • Pfizer CT.gov Call Center · Pfizer

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-07-31
Primary Completion
2013-03-31
Completion
2013-03-31

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01322633 on ClinicalTrials.gov